BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Pharm Country

  Henry Schein, Inc. Climbs to #292 On The FORTUNE 500®

  June 3, 2014

   · 

  2 min read
• Drug Development

  Cerulean Pharma Inc. Announces CRLX101 Combination Data At 2014 American Society of Clinical Oncology Annual Meeting

  June 3, 2014

   · 

  1 min read
• Biotech Beach

  Aeolus Pharmaceuticals Inc. To Present At LD Micro Invitational Conference

  June 3, 2014

   · 

  4 min read
• BioForest

  Plandai Biotechnology, Inc. Awarded $1.3 Million Grant From South African Department Of Trade & Industry

  June 3, 2014

   · 

  3 min read
• Drug Development

  Novartis AG’s Bone Marrow Drug LBH589 Improves Progression-Free Survival In Key Phase 3 Trial

  June 3, 2014

   · 

  9 min read
• Policy

  FDA Gives ProSensa Holding N.V.'s Lead Drug Drisapersen A New Path Towards Approval

  June 3, 2014

   · 

  7 min read
• Nanotherapeutics Secures $30 Million Loan

  June 3, 2014

   · 

  2 min read
• Drug Development

  Eli Lilly and Company’s CYRAMZA™ (ramucirumab) Significantly Improves Overall Survival In Phase 3 Non-Small Cell Lung Cancer Study

  June 3, 2014

   · 

  15 min read
• Deals

  NPS Pharmaceuticals, Inc. Denies Any Contact From Shire Over Possible Takeover

  June 3, 2014

   · 

  1 min read
• Drug Development

  Novartis AG’s Drug Zykadia™ Shrank Tumors In Phase 1 Study

  June 3, 2014

   · 

  14 min read